Passive immunization for RSV prevention is recommended for children aged newborn to 2 years. It helps reduce the risk of infection from Respiratory Syncytial Virus (RSV)—a leading cause of serious respiratory illnesses such as bronchiolitis and pneumonia in infants.
Vaccinating early helps build immunity before illness occurs, reducing the chances of hospitalization and severe complications during high-risk seasons.
Infants aged 0–2 years
Premature babies or children with underlying health conditions
Young children during high-risk periods, such as the rainy season or when attending daycare
Prevents severe respiratory tract infections in infants
Reduces risk of complications such as pneumonia
Lowers the chance of hospitalization
Strengthens immunity during a child’s most vulnerable stage
RSV immunization for infants (under 1 year old), single dose
For newborns - 1 month old:
Weight not exceeding 5 kg.
Recommendations:
This vaccine is recommended for infants under 1 year of age, especially those at risk such as premature babies or those with underlying medical conditions. Consult a pediatrician before receiving the vaccine.
RSV vaccine for children aged 12 to 24 months – 2 doses
For ages 1 month - 12 months
Weight not exceeding 5 kg.
RSV Immunotherapy (Beyfortus)
For ages 12 months - 24 months.
Sales period: This Day to 31 August 2026
For more information, please contact
Department of Pediatrics and Child Development, Building 4, 2nd Floor, Tel. 02-561-1111 ext. 4201-4202
Privacy Policy | Cookie Policy
Copyright © Vibhavadi Hospital. All right reserved